ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
어셔 증후군 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 5.7%의 CAGR로 28억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 인공와우 사용 증가, 유전자 돌연변이 증가, 의료비 지출 증가, 안과 재활의 인기 증가, 청각 재활의 채택 확대 등에 기인합니다. 이 기간의 주요 동향으로는 백신 개발, 보청기 발전, 의료기기 혁신, 수술 기술 향상, 유전자 치료의 발전 등을 꼽을 수 있습니다.
유전성 질환의 유병률 증가는 애셔 증후군 시장의 성장을 견인할 것으로 예상됩니다. 유전성 질환은 DNA를 통해 부모로부터 자녀에게 전달되는 유전적 질환으로, 종종 하나 이상의 유전자 돌연변이로 인해 발생합니다. 유전성 질환의 증가는 부모 연령의 증가와 관련이 있으며, 신생아의 유전성 질환 발생률 증가로 이어집니다. 어셔 증후군, 유전성 질환은 조기 진단, 전문 치료, 표적 치료가 필요합니다. 유전 질환에 대한 인식과 검진에 대한 인식이 높아짐에 따라 어셔 증후군의 사례가 더 많이 확인되어 진단 검사, 유전 상담 및 치료 개입에 대한 수요가 증가하고 있습니다. 예를 들어, 2022년 11월 영국 혈우병 센터 의사기구는 2세 이상의 중증 혈우병 A 신규 등록자 수가 2021년 16명에서 2022년 19명으로 증가했다고 보고했습니다. 따라서 유전성 질환의 유병률 증가는 어셔 증후군 시장의 성장을 촉진할 것으로 예상됩니다.
어셔 증후군 시장의 주요 기업들은 시력 및 청력 저하를 지연시키거나 회복시키는 것을 목표로 하는 유전자 치료 및 혁신적인 치료법을 개발하기 위한 임상 연구에 집중하고 있습니다. 이러한 임상 연구는 조기 진단을 개선하고, 보조 기술을 강화하며, 보다 효과적인 질병 관리를 위한 약물 기반 개입의 가능성을 모색하고 있습니다. 예를 들어, 이탈리아에 본사를 둔 생명공학 기업 AAVantgarde Bio는 2024년 10월, 망막색소변성증 1B형(USH1B)에 대한 유전자 치료제 AAVB-081의 안전성과 유효성을 평가하기 위한 I/II상 임상시험인 LUCE-1을 시작했습니다. 이 임상은 망막 건강에 필수적인 MYO7A 유전자의 기능적 복제본을 도입한 AAVB-081의 안전성과 내약성을 평가하기 위해 설계됐습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 어셔 증후군 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 어셔 증후군 시장 : 성장률 분석
세계의 어셔 증후군 시장 실적 : 규모와 성장, 2019-2024
세계의 어셔 증후군 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 어셔 증후군 전체 시장(TAM)
제6장 시장 세분화
세계의 어셔 증후군 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
유형 1
유형 2
유형 3
기타 유형
세계의 어셔 증후군 시장 치료별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
디바이스
약물
치료
기타 치료법
세계의 어셔 증후군 시장 진단별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
망막전도
광간섭단층촬영
비디오 안진검사
청각학
유전자 검사
기타 진단
세계의 어셔 증후군 시장 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
기타 유통 채널
세계의 어셔 증후군 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 어셔 증후군 시장, 기타 유형 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
비정형 어셔 증후군
희소 유전자 변이
제7장 지역별·국가별 분석
세계의 어셔 증후군 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 어셔 증후군 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
어셔 증후군 시장 : 경쟁 구도
어셔 증후군 시장 : 기업 개요
National Institute Of Health Overview, Products and Services, Strategy and Financial Analysis
Stanford Health Care Overview, Products and Services, Strategy and Financial Analysis
Cochlear Ltd Overview, Products and Services, Strategy and Financial Analysis
Advanced Bionics AG Overview, Products and Services, Strategy and Financial Analysis
Spark Therapeutics Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Editas Medicine Inc
American Academy of Ophthalmology
BlueRock Therapeutics
Medline Plus
Ear Science Institute Australia
Oxford Academics
ProQR Therapeutics NV
ReiThera srl
Usher Syndrome Coalition
Happy Ears Hearing Center
Odylia Therapeutics
ReNeuron Group plc
Sensorion SAS
Gensight Biologics
Harvard Medical School
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
어셔 증후군 시장 2029 : 새로운 기회를 제공하는 국가
어셔 증후군 시장 2029 : 새로운 기회를 제공하는 부문
어셔 증후군 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Usher syndrome is a genetic disorder that affects both hearing and vision, often resulting in deafness or hearing loss, along with a progressive eye condition known as retinitis pigmentosa (RP). It is the leading cause of combined deaf-blindness and follows an autosomal recessive inheritance pattern.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main categories in the Usher syndrome market are type 1, type 2, type 3, and other types. Type 1 Usher syndrome is the most severe form, characterized by profound deafness from birth, significant balance issues, and early-onset vision loss due to retinitis pigmentosa (RP). Treatment options include devices, drugs, therapy, and other methods. Diagnostic tools include electroretinograms, optical coherence tomography, video hysterography, audiology, genetic testing, and other assessments. Distribution channels include hospital pharmacies, retail pharmacies, and other outlets. End-users of these treatments include hospitals, specialty clinics, and other healthcare settings.
The usher syndrome market research report is one of a series of new reports from The Business Research Company that provides usher syndrome market statistics, including usher syndrome industry global market size, regional shares, competitors with an usher syndrome market share, detailed usher syndrome market segments, market trends and opportunities, and any further data you may need to thrive in the usher syndrome industry. This usher syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The usher syndrome market size has grown strongly in recent years. It will grow from $2.13 billion in 2024 to $2.25 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth observed during the historic period can be attributed to the increasing prevalence of genetic disorders, a growing demand for minimally invasive surgeries, a rise in inherited disorders, more product approvals, and the expansion of government initiatives.
The usher syndrome market size is expected to see strong growth in the next few years. It will grow to $2.81 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth projected during the forecast period can be attributed to the increasing use of cochlear implants, a rise in gene mutations, growing healthcare expenditure, the increasing popularity of ophthalmological rehabilitation, and a greater adoption of audiological rehabilitation. Key trends during this period include the development of vaccines, advancements in hearing aids, innovations in medical devices, improvements in surgical techniques, and progress in gene therapies.
The growing prevalence of inherited disorders is expected to drive the expansion of the Usher syndrome market. Inherited disorders are genetic conditions passed from parents to their offspring through DNA, often due to mutations in one or more genes. The rise in inherited disorders is linked to increasing parental age, which leads to a higher incidence of genetic conditions in newborns. Usher syndrome, a genetic disorder, requires early diagnosis, specialized care, and targeted treatments. The growing awareness and screening for genetic conditions are resulting in more cases of Usher syndrome being identified, thereby increasing the demand for diagnostic tests, genetic counseling, and therapeutic interventions. For example, in November 2022, the United Kingdom Hemophilia Centre Doctors Organization reported an increase in new registrations for individuals aged 2 years and older with severe hemophilia A, rising from 16 in 2021 to 19 in 2022. Therefore, the rising prevalence of inherited disorders is expected to drive the growth of the Usher syndrome market.
Leading companies in the Usher syndrome market are focusing on clinical studies to develop gene therapies and innovative treatments aimed at slowing or reversing vision and hearing loss. These clinical studies seek to improve early diagnosis, enhance assistive technologies, and explore potential drug-based interventions for more effective disease management. For instance, in October 2024, AAVantgarde Bio, an Italy-based biotechnology company, launched the LUCE-1 trial, a Phase I/II clinical study to evaluate the safety and efficacy of its gene therapy, AAVB-081, for treating retinitis pigmentosa associated with Usher Syndrome type 1B (USH1B). The trial is designed to assess the safety and tolerability of AAVB-081, which delivers a functional copy of the MYO7A gene, essential for retinal health.
In December 2023, Laboratoires Thea, a France-based pharmaceutical company, acquired sepofarsen and ultevursen from ProQR Therapeutics for an undisclosed amount. This acquisition aims to further the clinical development of sepofarsen and ultevursen for treating inherited retinal diseases such as LCA10 and Usher syndrome 2A. ProQR Therapeutics NV, a biotechnology company based in the Netherlands, focuses on developing treatments for Usher syndrome type 2. This acquisition will enable Laboratoires Thea to advance these therapies, enhancing the potential treatment options for late-stage eye diseases.
Major players in the usher syndrome market are National Institute Of Health, Stanford Health Care, Cochlear Ltd, Advanced Bionics AG, Spark Therapeutics, Editas Medicine Inc, American Academy of Ophthalmology, BlueRock Therapeutics, Medline Plus, Ear Science Institute Australia, Oxford Academics, ProQR Therapeutics NV, ReiThera srl, Usher Syndrome Coalition, Happy Ears Hearing Center, Odylia Therapeutics, ReNeuron Group plc, Sensorion SAS, Gensight Biologics, Harvard Medical School.
North America was the largest region in the usher syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in usher syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the usher syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The usher syndrome market consists of revenues earned by entities by providing services such as audiology services, vision rehabilitation, genetic counseling, and mobility training. The market value includes the value of related goods sold by the service provider or included within the service offering. The usher syndrome market also includes sales of hearing aids, cochlear implants, assistive listening devices, and low-vision aids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Usher Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on usher syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for usher syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The usher syndrome market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Type 1; Type 2; Type 3; Other Types
2) By Treatment: Devices; Drugs; Therapy; Other Treatments
3) By Diagnosis: Electroretinogram; Optical Coherence Tomography; Video Nystagmography; Audiology; Genetic Testing; Other Diagnoses
4) By Distribution Channels: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channels
5) By End-Users: Hospitals; Speciality Clinics; Other End-Users
Subsegments:
1) By Type 1: MYO7A Mutation; USH1C Mutation; CDH23 Mutation; PCDH15 Mutation; USH1G Mutation
2) By Type 2: USH2A Mutation; GPR98 Mutation; DFNB31 Mutation
3) Type 3: CLRN1 Mutation
4) Other Types: Atypical Usher Syndrome; Rare Genetic Variants
Companies Mentioned: National Institute Of Health; Stanford Health Care; Cochlear Ltd; Advanced Bionics AG; Spark Therapeutics
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Usher Syndrome Market Characteristics
3. Usher Syndrome Market Trends And Strategies
4. Usher Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Usher Syndrome Growth Analysis And Strategic Analysis Framework
5.1. Global Usher Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Usher Syndrome Market Growth Rate Analysis
5.4. Global Usher Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Usher Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Usher Syndrome Total Addressable Market (TAM)
6. Usher Syndrome Market Segmentation
6.1. Global Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Type 1
Type 2
Type 3
Other Types
6.2. Global Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Devices
Drugs
Therapy
Other Treatments
6.3. Global Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Electroretinogram
Optical Coherence Tomography
Video Nystagmography
Audiology
Genetic Testing
Other Diagnoses
6.4. Global Usher Syndrome Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Other Distribution Channels
6.5. Global Usher Syndrome Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Other End-Users
6.6. Global Usher Syndrome Market, Sub-Segmentation Of Type 1, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
MYO7A Mutation
USH1C Mutation
CDH23 Mutation
PCDH15 Mutation
USH1G Mutation
6.7. Global Usher Syndrome Market, Sub-Segmentation Of Type 2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
USH2A Mutation
GPR98 Mutation
DFNB31 Mutation
6.8. Global Usher Syndrome Market, Sub-Segmentation Of Type 3, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CLRN1 Mutation
6.9. Global Usher Syndrome Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Atypical Usher Syndrome
Rare Genetic Variants
7. Usher Syndrome Market Regional And Country Analysis
7.1. Global Usher Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Usher Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Usher Syndrome Market
8.1. Asia-Pacific Usher Syndrome Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Usher Syndrome Market
9.1. China Usher Syndrome Market Overview
9.2. China Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Usher Syndrome Market
10.1. India Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Usher Syndrome Market
11.1. Japan Usher Syndrome Market Overview
11.2. Japan Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Usher Syndrome Market
12.1. Australia Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Usher Syndrome Market
13.1. Indonesia Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Usher Syndrome Market
14.1. South Korea Usher Syndrome Market Overview
14.2. South Korea Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Usher Syndrome Market
15.1. Western Europe Usher Syndrome Market Overview
15.2. Western Europe Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Usher Syndrome Market
16.1. UK Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Usher Syndrome Market
17.1. Germany Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Usher Syndrome Market
18.1. France Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Usher Syndrome Market
19.1. Italy Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Usher Syndrome Market
20.1. Spain Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Usher Syndrome Market
21.1. Eastern Europe Usher Syndrome Market Overview
21.2. Eastern Europe Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Usher Syndrome Market
22.1. Russia Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Usher Syndrome Market
23.1. North America Usher Syndrome Market Overview
23.2. North America Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Usher Syndrome Market
24.1. USA Usher Syndrome Market Overview
24.2. USA Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Usher Syndrome Market
25.1. Canada Usher Syndrome Market Overview
25.2. Canada Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Usher Syndrome Market
26.1. South America Usher Syndrome Market Overview
26.2. South America Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Usher Syndrome Market
27.1. Brazil Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Usher Syndrome Market
28.1. Middle East Usher Syndrome Market Overview
28.2. Middle East Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Usher Syndrome Market
29.1. Africa Usher Syndrome Market Overview
29.2. Africa Usher Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Usher Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Usher Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Usher Syndrome Market Competitive Landscape And Company Profiles
30.1. Usher Syndrome Market Competitive Landscape
30.2. Usher Syndrome Market Company Profiles
30.2.1. National Institute Of Health Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Stanford Health Care Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Cochlear Ltd Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Advanced Bionics AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Spark Therapeutics Overview, Products and Services, Strategy and Financial Analysis
31. Usher Syndrome Market Other Major And Innovative Companies
31.1. Editas Medicine Inc
31.2. American Academy of Ophthalmology
31.3. BlueRock Therapeutics
31.4. Medline Plus
31.5. Ear Science Institute Australia
31.6. Oxford Academics
31.7. ProQR Therapeutics NV
31.8. ReiThera srl
31.9. Usher Syndrome Coalition
31.10. Happy Ears Hearing Center
31.11. Odylia Therapeutics
31.12. ReNeuron Group plc
31.13. Sensorion SAS
31.14. Gensight Biologics
31.15. Harvard Medical School
32. Global Usher Syndrome Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Usher Syndrome Market
34. Recent Developments In The Usher Syndrome Market
35. Usher Syndrome Market High Potential Countries, Segments and Strategies
35.1 Usher Syndrome Market In 2029 - Countries Offering Most New Opportunities
35.2 Usher Syndrome Market In 2029 - Segments Offering Most New Opportunities
35.3 Usher Syndrome Market In 2029 - Growth Strategies
